A detailed history of Principal Securities, Inc. transactions in Guardant Health, Inc. stock. As of the latest transaction made, Principal Securities, Inc. holds 154 shares of GH stock, worth $3,652. This represents 0.0% of its overall portfolio holdings.

Number of Shares
154
Previous 132 16.67%
Holding current value
$3,652
Previous $2.72 Million 63.35%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$16.07 - $31.84 $353 - $700
22 Added 16.67%
154 $4.45 Million
Q1 2024

May 10, 2024

SELL
$17.13 - $26.91 $582 - $914
-34 Reduced 20.48%
132 $2.72 Million
Q4 2023

Feb 07, 2024

BUY
$21.58 - $29.5 $3,582 - $4,897
166 New
166 $4.49 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $2.42B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Principal Securities, Inc. Portfolio

Follow Principal Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Principal Securities, Inc. with notifications on news.